Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Rapid genomic first- and second-line drug resistance prediction from clinical Mycobacterium tuberculosis specimens using Deeplex-MycTB

6 Aug 2020

Abstract excerpt

Targeted next generation sequencing using the Deeplex-MycTB assay can rapidly generate comprehensive drug resistance profiles from Mycobacterium tuberculosis complex cultures and directly from tuberculosis patient samples to guide personalised treatmenthttps://bit.ly/3dP1eIp

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Mycobacterium research and diagnosis
Share to Tuberculosis Research and Epidemiology
Share to vaccines and immunoinformatics approaches

Methodology Data sources Editorial policy Privacy Delete account & data About Contact Helena Bioinformatics

Source

Identifiers

PMID: 32764113
DOI: 10.1183/13993003.01796-2020

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 23 Oct 2026.

Related research

Semantic proximity does not establish scientific evidence. Graph snapshot: 2026-09-29.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Rapid genomic first- and second-line drug resistance prediction from clinical Mycobacterium tuberculosis specimens using Deeplex-MycTBPMID 32764113Read ↗

Deep amplicon sequencing for culture-free prediction of susceptibility or resistance to 13 anti-tuberculous drugs.Semantic proximity Read ↗

Rapid determination of anti-tuberculosis drug resistance from whole-genome sequencesSemantic proximity Read ↗

Targeted sequencing from cerebrospinal fluid for rapid identification of drug-resistant tuberculous meningitisSemantic proximity Read ↗

Direct detection of drug-resistant Mycobacterium tuberculosis using targeted next generation sequencingSemantic proximity Read ↗

Performance of a targeted next generation sequencing assay for mycobacterial identification and drug resistance from sputum and isolates.Semantic proximity Read ↗

Rapid drug resistance prediction in positive Mycobacterium tuberculosis clinical samples using an extensive targeted next-generation sequencing panel.Semantic proximity Read ↗

A Comprehensive Evaluation of GeneLEAD VIII DNA Platform Combined to Deeplex Myc-TB® Assay to Detect in 8 Days Drug Resistance to 13 Antituberculous Drugs and Transmission of Mycobacterium tuberculosis Complex Directly From Clinical SamplesSemantic proximity Read ↗

Leveraging large-scale Mycobacterium tuberculosis whole genome sequence data to characterise drug-resistant mutations using machine learning and statistical approaches.Semantic proximity Read ↗

Drug-Resistant Tuberculosis: A Glance at Progress and Global Challenges.Semantic proximity Read ↗

GenTB: A user-friendly genome-based predictor for tuberculosis resistance powered by machine learningSemantic proximity Read ↗

A data compendium associating the genomes of 12,289 Mycobacterium tuberculosis isolates with quantitative resistance phenotypes to 13 antibiotics.Semantic proximity Read ↗

Compact Targeted Next-Generation Sequencing for Rapid Diagnosis of Drug-Resistant Tuberculosis using Minimum BiocontainmentSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.